Surgical treatment for mediastinal parathyroid adenoma causing primary hyperparathyroidism by Masahiro Kitada et al.
RESEARCH ARTICLE Open Access
Surgical treatment for mediastinal
parathyroid adenoma causing primary
hyperparathyroidism
Masahiro Kitada*, Shunsuke Yasuda, Takahashi Nana, Kei Ishibashi, Satoshi Hayashi and Satoru Okazaki
Abstract
Background: Primary hyperparathyroidism is a rare disease characterized by excessive secretion of
parathyroid hormone from parathyroid adenoma, hyperplasia, or malignancy. The clinical symptoms of the
condition are those of hypercalcemia. Although the lesions are commonly located in the neck region, in
about 1–2 % of cases, the lesions are ectopically located within the mediastinum, where surgical excision
using the cervical approach is difficult. The principal treatment of the condition is surgical excision of the
lesion. However, some patients require additional surgery because of recurrence due to intraoperative
dissemination. Therefore, safe and accurate excision is essential for the treatment. We reviewed the
surgical treatment used at our institution for mediastinal parathyroid adenoma that caused primary
hyperparathyroidism.
Method: The subjects were four patients with primary hyperparathyroidism due to mediastinal
parathyroid adenoma who underwent surgery at our institution within a period of 10 years, between
January 2005 and December 2014. All of the patients were female, with a mean age of 64.5 years (range,
55–74 years). The examined variables included background factors, clinical condition, surgical method, and
clinical outcome.
Result: In all of the patients, primary hyperparathyroidism was detected with symptoms of hypercalcemia.
Laboratory tests revealed a mean serum calcium level of 11.85 mg/dL (range, 11.2–13.2 mg/dL) and a mean
parathyroid hormone (intact PTH) level of 304.8 pg/mL (range, 126–586 pg/mL), indicating elevated levels
for all patients. Chest computed tomography (CT) revealed tumors with a mean diameter of 2.8 cm (range,
10–45 mm) in the anterior mediastinum in all of the patients. On 99mTC-methoxy isobutyl isonitrile (MIBI)
scintigraphy, abnormal accumulation was observed in all of the patients. Regarding the surgical methods,
median sternotomy was used for three cases and upper partial sternotomy was used for one case. The
surgery was safely and accurately performed, without postoperative complications. After surgery, the serum
calcium levels immediately returned to normal and the symptoms improved.
Conclusion: We performed excision safely and accurately in all of the patients. In tumor identification,
99mTC-MIBI scintigraphy was useful. Accurate tumor identification and selection of the optimal surgical
method are important for prevention of recurrence due to intraoperative dissemination.
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Background
Primary hyperparathyroidism is a disease with various
symptoms related to hypercalcemia due to excessive
secretion of parathyroid hormone from a tumor or
hyperplasia, such as adenoma and carcinoma, which
arises in the parathyroid. The principal treatment of the
condition is surgical excision of the pathological tissue.
Although most parathyroid adenomas are located in the
neck region, 11–25 % of them are located within the
mediastinum and 1–2 % are located in the mediastinum,
where surgical excision using the cervical approach is
difficult [1–3]. We experienced surgical treatment of a
mediastinal parathyroid adenoma that caused primary
hyperparathyroidism in four patients.
Method
The subjects were four patients with primary hyperpara-
thyroidism due to mediastinal parathyroid adenoma who
underwent surgery at our institution within a period of
10 years, between January 2005 and December 2014. All
of the patients were female, with a mean age of 64.5 years
(range, 55–74 years). The examined variables included
background factors, symptoms at the time of diagnosis,
clinical condition, surgical method, and clinical outcome.
Result
The clinical symptoms of and surgical methods used for
all the patients are shown in Table 1. In all of the
patients, primary hyperparathyroidism was detected with
the following symptoms of hypercalcemia: two patients
presented with weakness, including muscle strength
reduction; one presented with urinary calculus; and the
remaining patient presented with digestive symptoms
such as nausea and abdominal pain. Laboratory tests
showed a mean serum calcium level of 11.85 mg/dL
(range, 11.2–13.2 mg/dL) and a mean intact PTH level
of 304.8 pg/mL (range, 126–586 pg/mL), indicating
elevated levels in all of the patients. Chest CT revealed
tumors with a mean diameter of 2.8 cm (range, 10–45 mm)
in the anterior mediastinum in all of the patients. One
patient had a cystic tumor (case 3; Fig. 1). On 99mTC-
MIBI scintigraphy, abnormal accumulation was observed in
all of the patients (Fig. 2). Regarding the surgical methods,
median sternotomy was used for cases 1, 2, and 3, and
upper partial sternotomy was used for case 4. The surgery
was safely and accurately performed. After surgery, the
serum calcium levels immediately returned to normal, and
the symptoms improved without recurrence. According to
histological examination results, three patients were diag-
nosed with parathyroid adenoma and the remaining patient
was diagnosed with parathyroid hyperplasia. None of the
patients had any malignancy. Among the three patients
with adenoma, one had a cystic mass.
Discussion
Most cases of primary hyperparathyroidism are caused
by excessive secretion of intact PTH from parathyroid
adenoma or parathyroid hyperplasia. About 90 % of
patients are women. The mean age of the patients is
reportedly around 60 years. The disease is usually
detected with symptoms of hypercalcemia, including
urinary calculus, bone lesion (osteoporosis), polyposia
and polyuria, general malaise, vomiting, and constipa-
tion. Recently, in a number of patients, the disease has
been detected incidentally during routine medical
checkup, according to laboratory test results that show
hypercalcemia, even without typical clinical symptoms.
The condition can occur as a part of multiple endocrine
neoplasia type 1 (MEN1), which consists of primary
hyperparathyroidism, gastroenteropancreatic neuroendo-
crine tumor, and pituitary adenoma [4, 5]. Most parathy-
roid adenomas are located in the neck region and
mediastinum. In particular, 11–25 % of parathyroid
adenomas are located within the mediastinum, of which
about 2 % are difficult to excise by using the cervical
approach [1–3]. In addition, mediastinal parathyroid aden-
omas are frequently small; therefore, accurate localization is
essential [6]. In addition, 99TC-MIBI scintigraphy is useful
Table 1 Characteristics of patients with hyperthyroidism in whom mediastinal lesions and surgical approach, pathology,
clinical outcome
Case 1 2 3 4
Age 57 72 74 55
Gender women women women women
Chief complaint nephrolithiasis listlessness listlessness abdominal pain feel nausea
Serum calcium level (mg/dl) 11.1 11.2 13.2 11.9
intact-PTH (pg/dl) 126 353 586 154
Location anterior mediastinum anterior mediastinum anterior mediastinum anterior mediastinum
Surgical approach Total sternotomy Total sternotomy Total sternotomy Partial sternotomy
Pathology adenoma adenoma adenoma hyperplasia
Post operative hyperthyroidism cured cured cured cured
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for localization of the tumor and therefore essential
for preoperative diagnosis [1, 7]. Previous studies also
reported the usefulness of longitudinal vein harvesting
[8, 9] and monitoring of serum PTH (intraoperative
PTH) levels [10].
While a study reported a successful treatment of the
condition with percutaneous ethanol injection, [11] most
cases require tumor excision. Conventionally, median
sternotomy has been used for surgical excision of medi-
astinal parathyroid adenomas that are difficult to excise
using the cervical approach. This method has advantages
of accuracy in tumor identification and good operative
view. However, given that most of the tumors are
benign, less-invasive approaches have gained popularity.
In addition to cases of upper partial sternotomy, cases of
thoracoscopic excision [12, 13] and excision through
parasternal intercostal incision have been reported [14].
Therefore, selection of the optimal surgical approach for
each patient is important for accurate tumor identification
and excision.
Fig. 1 Computerized tomography. Mediastinum parathyroid adenoma or hyperplasia legion (arrow)
Fig. 2 99mTc MIBI scan. Mediastinum parathyroid adenoma or hyperplasia lesion (arrow). Image of case3 and 4 are subtraction image
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Conclusion
We reviewed the surgical treatment used in our institution
for four cases of ectopic mediastinal parathyroid adenoma
that caused primary hyperparathyroidism. Accurate tumor
identification and selection of the optimal surgical method
are important for prevention of recurrence due to intra-
operative dissemination.
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